MedPath

Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany

Recruiting
Conditions
07.1 COVID-19U07.2 Suspicion of COVID-19
Registration Number
DRKS00022335
Lead Sponsor
Helmholtz-Zentrum für Infektionsforschung GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60000
Inclusion Criteria

Included in sample taken via registration offices, sufficient knowledge of German for informed consent

Exclusion Criteria

Refusal of informed consent or contraindication to venipuncture

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath